Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 4219046)

Published in Pediatr Rheumatol Online J on October 23, 2014

Authors

Ilaria Pagnini1, Gabriele Simonini1, Loredana Cavalli2, Giancarlo la Marca1, Annamaria Iuliano3, Maria Luisa Brandi2, Francesca Bellisai3, Bruno Frediani3, Mauro Galeazzi3, Luca Cantarini3, Rolando Cimaz1

Author Affiliations

1: Department of Pediatrics, University of Florence, AOU Meyer, Rheumatology Unit, Viale Pieraccini 24, 50139 Florence, Italy.
2: Department of Endocrinology, University of Florence, Florence, Italy.
3: Department of Rheumatology, Policlinico Le Scotte, University of Siena, Siena, Italy.

Articles cited by this

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) BMJ (1997) 4.54

Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res (1996) 2.47

Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood (2005) 2.07

Review: developmental origins of osteoporotic fracture. Osteoporos Int (2005) 1.99

Intrauterine programming of adult body composition. J Clin Endocrinol Metab (2001) 1.76

Prenatal and childhood influences on osteoporosis. Best Pract Res Clin Endocrinol Metab (2002) 1.64

Boys live dangerously in the womb. Am J Hum Biol (2010) 1.60

Assessment of osteoporosis by quantitative ultrasound versus dual energy X-ray absorptiometry in children with chronic rheumatic diseases. J Rheumatol (2004) 1.57

Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. The International Quantitative Ultrasound Consensus Group. J Bone Miner Res (1997) 1.52

Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial. J Thromb Haemost (2007) 1.51

Does birthweight predict bone mass in adulthood? A systematic review and meta-analysis. Osteoporos Int (2010) 1.44

Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost (1999) 1.31

Genetic and environmental determinants of peak bone mass in young men and women. J Bone Miner Res (2002) 1.27

Phalangeal osteosonogrammetry study: age-related changes, diagnostic sensitivity, and discrimination power. The Phalangeal Osteosonogrammetry Study Group. J Bone Miner Res (2000) 1.13

The effects of heparin and low molecular weight heparins on bone. Thromb Res (2007) 1.11

Ultrasound assessment of bone. J Bone Miner Res (1993) 1.08

Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab (2011) 1.02

Efficient analysis of urinary glycosaminoglycans by LC-MS/MS in mucopolysaccharidoses type I, II and VI. Mol Genet Metab (2010) 0.98

Pregnancy in systemic lupus erythematosus. Postgrad Med J (2001) 0.97

Pregnancy- and lactation-associated osteoporosis: a narrative mini-review. Endocr Regul (2011) 0.96

Lupus and pregnancy. Obstet Gynecol Surv (2011) 0.95

Management of antiphospholipid syndrome. J Autoimmun (2009) 0.93

Low molecular weight heparin Novo (LHN-1) does not cross the placenta during the second trimester of pregnancy. Thromb Haemost (1989) 0.89

Absence of transplacental passage of the low molecular weight heparin enoxaparin. Haemostasis (2001) 0.88

Use of low molecular weight heparin in pregnancy. Thromb Haemost (1992) 0.88

The use of low-molecular-weight heparins in pregnancy--how safe are they? Curr Opin Obstet Gynecol (2007) 0.87

Growth and bone development. Nestle Nutr Workshop Ser Pediatr Program (2008) 0.86

The management of thrombosis in pregnancy: role of low-molecular-weight heparin. Thromb Haemost (2007) 0.85

Pathways of transmission of ultrasound energy through the distal metaphysis of the second phalanx of pigs: an in vitro study. Osteoporos Int (1996) 0.85

Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. Thromb Res (1984) 0.84

The assessment of development of bone mass in children by quantitative ultrasound through the proximal phalanxes of the hand. Ultrasound Med Biol (1997) 0.84

Prophylactic and therapeutic enoxaparin during pregnancy: indications, outcomes and monitoring. Aust N Z J Obstet Gynaecol (2003) 0.83

Comparison of quantitative calcaneal ultrasound and dual energy X-ray absorptiometry in the evaluation of osteoporotic risk in children with chronic rheumatic diseases. Calcif Tissue Int (2000) 0.83

Use of quantitative ultrasound to assess bone status in children with juvenile idiopathic arthritis: a pilot study. J Clin Densitom (2000) 0.82

A protocol for the use of enoxaparin during pregnancy: results from 85 pregnancies including 13 multiple gestation pregnancies. Clin Appl Thromb Hemost (2005) 0.82

Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Ann N Y Acad Sci (2005) 0.80

Hand ultrasound for osteoporosis screening in postmenopausal women. Osteoporos Int (2000) 0.79

Low molecular weight heparin (CY 216) does not cross the placenta during the third trimester of pregnancy. Thromb Haemost (1987) 0.79

No transplacental passage of standard heparin or an enzymatically depolymerized low molecular weight heparin. Blood Coagul Fibrinolysis (1991) 0.79

The correlation between phalangeal quantitative ultrasonography and dual energy x-ray absorptiometry in women with premature ovarian failure. Mcgill J Med (2008) 0.77

Placental transport of low molecular weight heparin in the pregnant sheep. Br J Haematol (1985) 0.76

Usefulness of bone ultrasound techniques in pediatric rheumatic diseases. J Rheumatol (2005) 0.76